Reducing the levels of the protein NEK2 in the pulmonary arteries may reverse vascular remodeling in PAH, a rat study showed.

A pivotal study testing Sensydia's noninvasive device, which may help diagnose pulmonary hypertension, enrolled its first ...

Synhale has acquired telaglenastat, and is planning a Phase 2 clinical trial testing the therapy in patients with pulmonary ...

Cereno Scientific reported a successful meeting with the FDA on the design of a future clinical trial for its PAH therapy ...

There are night owls and morning larks, writes columnist Colleen Steele, referring to people's sleep habits. So which bird are you?

PHA launched a certificate program for healthcare professionals, providing specialized training for PH diagnosis, treatment, ...

Leading up to my heart and lung transplant in 2018, a friend asked if there were any specific activities I was looking forward to doing post-transplant. The hope was that my health would improve ...